Over the past 10 years, osilodrostat has become one of the most commonly used steroidogenesis inhibitors in Cushing's syndrome. The starting dose is usually determined based on the product characteristics, the prescriber's experience, and cortisol levels. Ho... ...

请注册登录后继续浏览